INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi

NCT04945070 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

96

Enrollment

OTHER_GOV

Sponsor class

Conditions

Type 2 Diabetes Treated With Insulin

Interventions

DRUG: IGlarLixi
DRUG: MDI - Multiple dose insulin injection

Sponsor

Institute for Clinical and Experimental Medicine